标题
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-29
DOI
10.1038/s41416-019-0654-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutational processes shape the landscape of TP53 mutations in human cancer
- (2018) Andrew O. Giacomelli et al. NATURE GENETICS
- The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis
- (2017) Evgeny M. Makarov et al. PLoS One
- Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study
- (2015) L. Beltrame et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
- (2015) Brandon-Luke L. Seagle et al. GYNECOLOGIC ONCOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- TP53mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
- (2015) Jeremy Chien et al. NUCLEIC ACIDS RESEARCH
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- (2015) Roland F. Schwarz et al. PLOS MEDICINE
- Mutants TP53 p.R273H and p.R273C but not p.R273G Enhance Cancer Cell Malignancy
- (2014) Jie Li et al. HUMAN MUTATION
- Molecular Characterization of an Intact p53 Pathway Subtype in High-Grade Serous Ovarian Cancer
- (2014) Takahide Hayano et al. PLoS One
- Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance
- (2014) Ching-Yih Lin et al. TUMOR BIOLOGY
- Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
- (2013) B Zhang et al. BRITISH JOURNAL OF CANCER
- Not all p53 gain-of-function mutants are created equal
- (2013) S S Mello et al. CELL DEATH AND DIFFERENTIATION
- High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
- (2013) Lars O. Baumbusch et al. PLoS One
- Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma
- (2013) Hyo Jeong Kang et al. PLoS One
- Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
- (2012) Z. C. Wang et al. CLINICAL CANCER RESEARCH
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome
- (2012) Paulina M. Wojnarowicz et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
- (2011) M. Lindenbergh-van der Plas et al. CLINICAL CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
- (2010) Dong-Jun Peng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells
- (2010) Kazuhito Yoshikawa et al. BIOMEDICAL RESEARCH-TOKYO
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started